Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system
AJ Scheen - Drugs, 2004 - Springer
Type 2 diabetes mellitus is becoming a major health problem associated with excess
morbidity and mortality. As the prevalence of type 2 diabetes is rapidly increasing …
morbidity and mortality. As the prevalence of type 2 diabetes is rapidly increasing …
[HTML][HTML] Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
TW Gress, FJ Nieto, E Shahar… - … England Journal of …, 2000 - Mass Medical Soc
Background Previous research has suggested that thiazide diuretics and beta-blockers may
promote the development of type 2 diabetes mellitus. However, the results of these studies …
promote the development of type 2 diabetes mellitus. However, the results of these studies …
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II …
W Bestermann, MC Houston, RG Hawkins… - The American journal of …, 2005 - Elsevier
An aggressive global approach to screening and to the management of the metabolic
syndrome is recommended to slow the growth of the syndrome throughout the United States …
syndrome is recommended to slow the growth of the syndrome throughout the United States …
Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies
P Weidmann - Drug safety, 2001 - Springer
Objective: To evaluate the influence of indapamide sustained-release (SR) 1.5 mg/day, a
thiazide-related sulfonamide diuretic, on serum levels of lipids (total cholesterol, high …
thiazide-related sulfonamide diuretic, on serum levels of lipids (total cholesterol, high …
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients
T Kaiser, T Heise, L Nosek, U Eckers… - Journal of …, 2006 - journals.lww.com
Objective To compare the effects of a cardioselective beta-blocker (nebivolol) with those of
an angiotensin-converting enzyme inhibitor (enalapril) on parameters of insulin sensitivity …
an angiotensin-converting enzyme inhibitor (enalapril) on parameters of insulin sensitivity …
Safety of telmisartan in patients with arterial hypertension: an open-label observational study
MC Michel, H Bohner, J Köster, R Schäfers… - Drug Safety, 2004 - Springer
Objective: To determine whether age, gender, concomitant disease and/or previous or
present antihypertensive medication affect the safety or antihypertensive efficacy of …
present antihypertensive medication affect the safety or antihypertensive efficacy of …
Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: a randomized, double-blind, controlled study of 21 obese …
R Kuperstein, Z Sasson - Circulation, 2000 - Am Heart Assoc
Background—Glucose and insulin levels are associated with left ventricular mass (LVM) in
insulin-resistant individuals. Antihypertensive drugs have different effects on glucose and …
insulin-resistant individuals. Antihypertensive drugs have different effects on glucose and …
Renal protection and antihypertensive drugs: current status
A Salvetti, P Mattei, I Sudano - Drugs, 1999 - Springer
The renal protective effect of antihypertensive drugs is linked to 2 mechanisms. First,
reduction in blood pressure (BP) is a fundamental prerequisite common to all …
reduction in blood pressure (BP) is a fundamental prerequisite common to all …
Hypertension in patients with diabetes: strategies for drug therapy to reduce complications
JR Sowers, M Williams, M Epstein… - Postgraduate …, 2000 - Taylor & Francis
PREVIEW High blood pressure presents a major threat in patients with either type 1 or type
2 diabetes. It greatly increases the risks for such complications as end-stage renal disease …
2 diabetes. It greatly increases the risks for such complications as end-stage renal disease …
Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension
BNC Prichard, BA Jäger, JH Luszick, LJ Küster… - Blood …, 2002 - Taylor & Francis
Objectives: To compare the antihypertensive efficacy and tolerability of the imidazoline I-
receptor agonist moxonidine, administered as a single daily dose of 0.6 mg, with the …
receptor agonist moxonidine, administered as a single daily dose of 0.6 mg, with the …